Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-07-16

FDA Approved: SILODOSIN — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Silodosin submitted by Macleods Pharmaceuticals Limited. The action updates the labeling for Silodosin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silodosin (Silodosin)

Snippet

SUPPL AP for SILODOSIN (SILODOSIN)